BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28828217)

  • 1. A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients.
    Ceccarelli G; Fratino M; Selvaggi C; Giustini N; Serafino S; Schietroma I; Corano Scheri G; Pavone P; Passavanti G; Alunni Fegatelli D; Mezzaroma I; Antonelli G; Vullo V; Scagnolari C; d'Ettorre G
    Brain Behav; 2017 Aug; 7(8):e00756. PubMed ID: 28828217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals.
    Ceccarelli G; Brenchley JM; Cavallari EN; Scheri GC; Fratino M; Pinacchio C; Schietroma I; Fard SN; Scagnolari C; Mezzaroma I; Vullo V; d'Ettorre G
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29160817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients.
    d'Ettorre G; Rossi G; Scagnolari C; Andreotti M; Giustini N; Serafino S; Schietroma I; Scheri GC; Fard SN; Trinchieri V; Mastromarino P; Selvaggi C; Scarpona S; Fanello G; Fiocca F; Ceccarelli G; Antonelli G; Brenchley JM; Vullo V
    Immun Inflamm Dis; 2017 Sep; 5(3):244-260. PubMed ID: 28474815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment.
    Rondanelli M; Opizzi A; Faliva M; Mozzoni M; Antoniello N; Cazzola R; Savarè R; Cerutti R; Grossi E; Cestaro B
    Nutr Neurosci; 2012 Mar; 15(2):46-54. PubMed ID: 22334085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Various associations of aging and long-term HIV infection with different neurocognitive functions: detailed analysis of a Japanese nationwide multicenter study.
    Komatsu K; Kinai E; Sakamoto M; Taniguchi T; Nakao A; Sakata T; Iizuka A; Koyama T; Ogata T; Inui A; Oka S;
    J Neurovirol; 2019 Apr; 25(2):208-220. PubMed ID: 30859496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Activity of Fecal Water Samples from HIV-1 Infected Subjects Treated with a Specific Probiotic Formulation.
    Falasca F; Cavallari EN; Innocenti GP; Scagnolari C; Mezzaroma I; Santinelli L; Ceccarelli G; Vullo V; Turriziani O; d'Ettorre G
    Curr HIV Res; 2019; 17(3):183-189. PubMed ID: 31490760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV.
    Reale M; Ucciferri C; Costantini E; Di Nicola M; Porreca A; Di Giovanni P; Pontolillo M; Auricchio A; Vecchiet J; Falasca K
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.
    Sanford R; Fellows LK; Ances BM; Collins DL
    JAMA Neurol; 2018 Jan; 75(1):72-79. PubMed ID: 29131878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART.
    Stiksrud B; Nowak P; Nwosu FC; Kvale D; Thalme A; Sonnerborg A; Ueland PM; Holm K; Birkeland SE; Dahm AE; Sandset PM; Rudi K; Hov JR; Dyrhol-Riise AM; Trøseid M
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):329-37. PubMed ID: 26258571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials.
    Kim CJ; Walmsley SL; Raboud JM; Kovacs C; Coburn B; Rousseau R; Reinhard R; Rosenes R; Kaul R
    HIV Clin Trials; 2016 Jul; 17(4):147-57. PubMed ID: 27267710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation.
    Pinacchio C; Scheri GC; Statzu M; Santinelli L; Ceccarelli G; Innocenti GP; Vullo V; Antonelli G; Brenchley JM; d'Ettorre G; Scagnolari C
    J Immunol Res; 2018; 2018():1738676. PubMed ID: 30186879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative Evaluation of the Immediate Copy of the Rey-Osterrieth Complex Figure: Comparison Between Vascular and Degenerative MCI Patients.
    Salvadori E; Dieci F; Caffarra P; Pantoni L
    Arch Clin Neuropsychol; 2019 Feb; 34(1):14-23. PubMed ID: 29420698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D is associated with visual memory in young northern adolescents.
    Bailey KRF; Pettersen JA
    Nutr Neurosci; 2024 Apr; 27(4):392-403. PubMed ID: 37029691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine levels in CSF and neuropsychological performance in HIV patients.
    Nolting T; Lindecke A; Hartung HP; Koutsilieri E; Maschke M; Husstedt IW; Sopper S; Stüve O; Arendt G;
    J Neurovirol; 2012 Jun; 18(3):157-61. PubMed ID: 22528475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy.
    Janssen MA; Meulenbroek O; Steens SC; Góraj B; Bosch M; Koopmans PP; Kessels RP
    AIDS; 2015 Oct; 29(16):2139-48. PubMed ID: 26544578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social cognitive and neurocognitive deficits in inpatients with unilateral thalamic lesions - pilot study.
    Wilkos E; Brown TJ; Slawinska K; Kucharska KA
    Neuropsychiatr Dis Treat; 2015; 11():1031-8. PubMed ID: 25914535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment.
    Ulfhammer G; Edén A; Mellgren Å; Fuchs D; Zetterberg H; Hagberg L; Nilsson S; Yilmaz A; Gisslén M
    AIDS; 2018 Sep; 32(15):2171-2178. PubMed ID: 30005007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy.
    Kore I; Ananworanich J; Valcour V; Fletcher JL; Chalermchai T; Paul R; Reynolds J; Tipsuk S; Ubolyam S; Rattanamanee S; Jagodzinski L; Kim J; Spudich S;
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):393-9. PubMed ID: 26509933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders.
    Letendre SL; McCutchan JA; Childers ME; Woods SP; Lazzaretto D; Heaton RK; Grant I; Ellis RJ;
    Ann Neurol; 2004 Sep; 56(3):416-23. PubMed ID: 15349869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder.
    Gates TM; Cysique LA; Siefried KJ; Chaganti J; Moffat KJ; Brew BJ
    AIDS; 2016 Feb; 30(4):591-600. PubMed ID: 26825032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.